Cargando…

Transfusion Practices in the Management of Sickle Cell Disease: A Survey of Florida Hematologists/Oncologists

The purpose of this study was to characterize transfusion practices in the management of sickle cell disease and to identify factors attributing to differences in prescribing practices among Florida hematologists/oncologists. A cross-sectional study was performed in 2005-2006 utilizing a mail survey...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dunbar, Levette N., Coleman Brown, LaRae, Rivera, Donna R., Hartzema, Abraham G., Lottenberg, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scholarly Research Network 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3530784/ https://www.ncbi.nlm.nih.gov/pubmed/23316379 http://dx.doi.org/10.5402/2012/524513

Ejemplares similares

Physician approaches to drug shortages: Results of a national survey of pediatric hematologist/oncologists
por: Beck, Jill C, et al.
Publicado: (2017)

A survey of pediatric hematologists/oncologists’ perspectives on single patient Expanded Access and Right to Try
por: Chapman, Carolyn Riley, et al.
Publicado: (2021)

Burnout in US hematologists and oncologists: impact of compensation models and advanced practice provider support
por: Lee, Alfred Ian, et al.
Publicado: (2022)

Impact of legislation and public funding on oncofertility: a survey of Canadian, French and Moroccan pediatric hematologists/oncologists
por: Affdal, Aliya Oulaya, et al.
Publicado: (2020)

Current Status and Physicians’ Perspectives of Childhood Cancer Survivorship in Korea: A Nationwide Survey of Pediatric Hematologists/Oncologists
por: Lee, Ji Won, et al.
Publicado: (2023)

Applying spatial epidemiology to hematological disease using R: a guide for hematologists and oncologists
por: Kohno, Kei, et al.
Publicado: (2014)

Second wave of COVID-19 – Not a matter of great concern for pediatric hematologist/oncologist
por: Bansal, Minakshi, et al.
Publicado: (2022)

Hematologist encounters among Medicaid patients who have sickle cell disease
por: Horiuchi, Sophia S., et al.
Publicado: (2022)

Gaucher Disease for Hematologists
por: Özdemir, Gül Nihal, et al.
Publicado: (2022)

Evaluation of How Integrative Oncology Services Are Valued between Hematology/Oncology Patients and Hematologists/Oncologists at a Tertiary Care Center
por: Hansra, D. M., et al.
Publicado: (2018)

Differences in treatment goals and perception of symptom burden between patients with myeloproliferative neoplasms (MPNs) and hematologists/oncologists in the United States: Findings from the MPN Landmark survey
por: Mesa, Ruben A., et al.
Publicado: (2016)

PB2351: ANXIETY AT THE HEMATOLOGIST
por: Trojan, S., et al.
Publicado: (2022)

PB1943: THE EFFECTS OF AN ONLINE CURRICULUM BASED APPROACH TO CME ON HEMATOLOGIST/ONCOLOGISTS’ ABILITY TO TREAT PATIENTS WITH BTK INHIBITORS FOR B-CELL MALIGNANCIES
por: Bomba, Sarah Elizabeth, et al.
Publicado: (2023)

Shoulder pain: a hematologist’s perspective
por: Jain, Ankur, et al.
Publicado: (2016)

The Prevention of Cisplatin-Induced Nephrotoxicity: A General Consensus Statement of a Group of Oncologist-Hematologists, Adult and Pediatric Nephrologists, Radiation Oncologists, Clinical Pathologists, Clinical Pharmacologists, and Renal Physiologists on Cisplatin Therapy in Cancer Patients
por: Ashrafi, Farzaneh, et al.
Publicado: (2022)

Knowledge, Attitudes, and Practices of Hematologists Regarding Fertility Preservation in Turkey
por: Küçük, Mert, et al.
Publicado: (2013)

Acquired von Willebrand syndrome: focused for hematologists
por: Franchini, Massimo, et al.
Publicado: (2020)

Acute Mesenteric Thrombosis: A Hematologist Perspective
por: Moiz, Bushra, et al.
Publicado: (2020)

Cancer associated thrombosis: Which lessons for the hematologist?
por: Noble, Simon
Publicado: (2018)

Fluctuating neurological symptoms: should I call the neurologist or the hematologist?
por: Losa-Rodríguez, Rita, et al.
Publicado: (2020)

Mortality by COVID-19 in adults with acute myeloid leukemia: a survey with hematologists in Brazil
por: Fagundes, Evandro M., et al.
Publicado: (2021)

MORTALITY BY COVID-19 IN ADULTS WITH ACUTE MYELOID LEUKEMIA: A SURVEY WITH HEMATOLOGISTS IN BRAZIL
por: Martins, NNN, et al.
Publicado: (2021)

Universal iron fortification of foods: the view of a hematologist
por: Martins, José Murilo
Publicado: (2012)

Cancer-associated thrombosis (CAT) - New challenges for the hematologist
por: Brækkan, Sigrid
Publicado: (2018)

Introduction to a review series on COVID-19 and the hematologist
por: Ortel, Thomas L., et al.
Publicado: (2022)

PB2128: CLINICAL CONSENSUS ON FIRST-LINE (1L) TREATMENTS FOR TRANSPLANT-INELIGIBLE (TIE) PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): DELPHI PANEL OF US HEMATOLOGISTS AND ONCOLOGISTS
por: Fonseca, Rafael, et al.
Publicado: (2023)

Best practices for transfusion for patients with sickle cell disease
por: Wun, Ted, et al.
Publicado: (2010)

Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist’s perspective
por: Kritharis, Athena, et al.
Publicado: (2018)

Bortezomib Prescription Pattern for the Treatment of Multiple Myeloma by Hematologists in Nigeria
por: Korubo, Kaladada I., et al.
Publicado: (2017)

Immune targeting of the microenvironment in classical Hodgkin’s lymphoma: insights for the hematologist
por: Carreau, Nicole A., et al.
Publicado: (2019)

Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists
por: Crisà, Elena, et al.
Publicado: (2021)

Educational needs of hematologists and laboratory professionals regarding factor activity assays
por: Adcock, Dorothy M, et al.
Publicado: (2018)

Ten things the hematologist wants you to know about CAR-T cells
por: Böll, Boris, et al.
Publicado: (2020)

The Central Role of Fibrinolytic Response in COVID-19—A Hematologist’s Perspective
por: Kwaan, Hau C., et al.
Publicado: (2021)

Behavioral Patterns in Breaking Bad News Communication: An Ethnographic Study with Hematologists
por: Artioli, Giovanna, et al.
Publicado: (2022)

Practical Considerations for the Daratumumab Management in Portuguese Routine Clinical Practice: Recommendations From an Expert Panel of Hematologists
por: Geraldes, Catarina, et al.
Publicado: (2022)

Transfusion Practice, Post-Transfusion Complications and Risk Factors in Sickle Cell Disease in Senegal, West Africa
por: Seck, Moussa, et al.
Publicado: (2022)

O-07: TRANSFUSION PRACTICE, POST-TRANSFUSION COMPLICATIONS AND RISK FACTORS IN SICKLE CELL DISEASE IN SENEGAL
por: M., SECK, et al.
Publicado: (2022)

IgG4-related disease: what a hematologist needs to know
por: Chen, Luke Y.C., et al.
Publicado: (2019)

SARS-CoV-2 Infected Patient: from a Hematologist’s Perspective
por: Kreidieh, Firas, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1v5lh5da18ghsanm6i0t95n6np